Going forward, PolyNovo and Beta Cell are in collaboration discussions to accelerate research anddevelopment pathways to ensure PolyNovo’s technology can play a major role in the cell therapy market space which is estimated to be USD $34 Billion by 2034
Wow there must be other applications for this cell therapy besides Type 1 Diabetes.
Ann: BTM delivers positive First in Man results in Cell Therapies, page-236
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.013(1.06%) |
Mkt cap ! $823.8M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.20 | $1.15 | $1.364M | 1.162M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 16386 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 25610 | 25 |
View Market Depth
| Last trade - 12.47pm 16/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |